CHD4-induced up-regulation of ERα activity contributes to breast cancer progression
Aman Sattout,
Xiaomin Yu,
Zhuo Sun,
Yanan Li,
Yulin Li,
Shujing Li,
Wei Huo,
Huijian Wu
Affiliations
Aman Sattout
School of Bioengineering & Key Laboratory of Protein Modification and Disease, Liaoning Province, Dalian University of Technology, Dalian, Liaoning 116024, China
Xiaomin Yu
Department of Oncology, Central Hospital Affiliated with Dalian University of Technology, Dalian, Liaoning 116089, China
Zhuo Sun
Department of Oncology, Central Hospital Affiliated with Dalian University of Technology, Dalian, Liaoning 116089, China
Yanan Li
School of Bioengineering & Key Laboratory of Protein Modification and Disease, Liaoning Province, Dalian University of Technology, Dalian, Liaoning 116024, China
Yulin Li
School of Bioengineering & Key Laboratory of Protein Modification and Disease, Liaoning Province, Dalian University of Technology, Dalian, Liaoning 116024, China
Shujing Li
School of Bioengineering & Key Laboratory of Protein Modification and Disease, Liaoning Province, Dalian University of Technology, Dalian, Liaoning 116024, China; Corresponding author.
Wei Huo
Department of Oncology, Central Hospital Affiliated with Dalian University of Technology, Dalian, Liaoning 116089, China; Corresponding author.
Huijian Wu
School of Bioengineering & Key Laboratory of Protein Modification and Disease, Liaoning Province, Dalian University of Technology, Dalian, Liaoning 116024, China; Corresponding author.
